SCHEMBL12096331

SCHEMBL12096331

CC(CC(N)=O)Nc1ccc(Br)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 2/20 0.47
CA12 O43570 1/20 0.43
MMP2 P08253 1/20 0.43
MMP9 P14780 1/20 0.43
MMP8 P22894 1/20 0.43
MMP14 P50281 1/20 0.43
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
SMN1; SMN2 Q16637 4/20 0.42
ALDH1A1 P00352 1/20 0.42
TP53 P04637 1/20 0.42
HSP90AA1 P07900 1/20 0.42
CYP3A4 P08684 1/20 0.42
THRB P10828 1/20 0.42
ALOX15 P16050 1/20 0.42
TSHR P16473 1/20 0.42
CASP1 P29466 1/20 0.42
HIF1A Q16665 1/20 0.42
HSD17B10 Q99714 1/20 0.42
TDP1 Q9NUW8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1820670 1.00 RAB9A (0.47) RAB9ACA12MMP2MMP9MMP8
SCHEMBL26130707 0.84 RAB9A (0.49) RAB9ACA12MMP2MMP9MMP8
SCHEMBL20288937 0.84 RAB9A (0.49) RAB9ACA12MMP2MMP9MMP8
SCHEMBL14223257 0.83 FPR2 (0.47) CA12MMP2MEN1KMT2ASMN1; SMN2
SCHEMBL4124134 0.82 TSHR (0.47) RAB9ACA12SMN1; SMN2ALDH1A1TP53
SCHEMBL4124137 0.82 TSHR (0.47) RAB9ACA12SMN1; SMN2ALDH1A1TP53
SCHEMBL7083712 0.80 ALDH1A1 (0.58) RAB9AMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL8996223 0.79 KIF11 (0.47) CA12MMP2MEN1KMT2AALDH1A1
SCHEMBL20270154 0.79 RAB9A (0.44) RAB9ACA12MMP2MMP9MMP8
SCHEMBL20269812 0.79 RAB9A (0.44) RAB9ACA12MMP2MMP9MMP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023196512-A1 PROPARGYL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THAT MODULATE BRD4 Plexium, Inc. (US) 2023-10-12 WO disclosed
EP-2496558-A1 THETRAHYDROQUINOLINES DERIVATIVES AS BROMODOMAIN INHIBITORS GlaxoSmithKline LLC (US) 2012-09-12 EP disclosed